Generic Semaglutide patent expiry opens over Rs 50,000 Crore opportunity for drugmakers: Report
Jan 03, 2026
In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth...